Report Categories
View AllRecent Articles
View All
Immunome Inc IMNM Q1 2026 Earnings Narrower Loss Beats Estimates Stock Gains Modestly
RILYN Q1 2024 Earnings Negative EPS and Bond Price Movement Amid Operational Challenges
SPRY Q1 2026 Earnings EPS Miss and Continued Cash Burn Amid Pipeline Development
UROY Q1 2026 Earnings Strong EPS Beat as Uranium Royalty Income Surprises
PRHI Q1 2024 Earnings Significant EPS Beat Fails to Impress Markets